An observational study in Arthralgia, sponsored by University Hospital, Lille. Completed at 2 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-05.
Sponsored by University Hospital, Lille · Observational
Among 15 studies in Arthralgia with a site in France — 3 open to participants now, 3 under way, 1 of them phase 3. Arthralgia · France.
Among the 15 studies in Arthralgia with a site in France, this one is one of 3 that started in 2018, is one of 3 observational ones, and was the 7th registered.
277 studies on the registry are indexed under Arthralgia; 54 are open to participants now.
Browse Arthralgia studies →3 of the 15 studies in Arthralgia with a site in France are open now. Recruiting first, the newest first:
Centre Hospitalier Universitaire de la Réunion · Sites in France
Ages 18+ · Healthy volunteers
Olatec Therapeutics, Inc. · Sites in France, United States, Israel and 2 more countries
Ages 18+
Hospices Civils de Lyon · Sites in France
Ages 18+ · Women only
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 35 Arthralgia studies recruiting now, 18 (51%) set no upper age limit and 16 (46%) stop at 75 or younger; 1 takes children under 18; 9 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
15 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 1 · Phase 3 5 · Phase 4 1
First in 2006; this study’s year is marked. 3 started in 2018.
This study's enrollment of 71 is below the median of 114 across 50 observational studies indexed under Arthralgia.
Median enrollment 123 across the 12 interventional studies, 99 across the 3 observational. Of the 8 that completed or were terminated, 4 (50%) have results posted.
This tab as a report to print or save as PDF → With an account.
7 of 15 have an industry lead sponsor. The 10 most frequent:
University Hospital, Lille is the lead sponsor of 631 studies on the registry; 142 are open to participants now.
University Hospital, Lille has 1 study filed under Arthralgia — fewer than ten, so there is no comparison to draw.
1 of the studies in Arthralgia with a site in France that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05658575Phase 3Olatec Therapeutics, Inc.Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare | 2026-12-31 |
Add it to your calendar (.ics) → With an account.
Among the 15 studies in Arthralgia with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Self-administered questionnaire survey to determine the presence or absence of joint pain during bevacizumab treatment for lung, ovarian, colorectal cancers.
The principal end-point is the frequency of arthralgia after 6 months of treatment with Bevacizumab.
Patients treated with Bevacizumab for Lung, ovarian or colorectal cancers.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
patients with ovarian, colorectal or bronchopulmonary cancer receiving Bevacizumab
Frequency of arthralgia
Frequency of joint manifestations of any grade according to the CTCAE (Common Terminology Criteria for Adverse Events) scale version 4.0 observed between the start of bevacizumab treatment and 6 months of treatment.
Time frame: At 6 months
correlation between global cancer response and occurrence of arthralgia
Time frame: baseline, at 3 months, at 6 months
auto questionnaire specific to the study
16 questions concerning the location, intensity, management of joint pain
Time frame: Baseline at 3 months, at 6 months
Ran from Jan 2018 to primary completion in Jan 2019, 12 months.
Of 21 observational studies under Arthralgia, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 56. This study's 12 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.